|
⚲
|
| Keyboard |
| Poelman Ronald S
✚
|
|
|---|---|
| CIK # | 0001203350 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001203350] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Usana Health Sciences Inc | |
| Poelman Ronald S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Usana Health Sciences Inc USNA
Deferred Stock Unit · derivative
|
2016-02-08 | Grant | 2,000 | ||
|
Usana Health Sciences Inc USNA
Common Stock
|
2015-05-20 | Option exercise | 1,570 | $28.16 | 44,211 |
|
Usana Health Sciences Inc USNA
Stock-Settled Stock Appreciation Rights · derivative
|
2015-05-20 | Option exercise | 2,000 | $0.00 | |
|
Usana Health Sciences Inc USNA
Common Stock
|
2015-05-20 | Sell | 1,570 | $131.00 | 205,670 |
|
Usana Health Sciences Inc USNA
Common Stock
|
2014-10-31 | Sell | 4,491 | $112.53 | 505,372 |
|
Usana Health Sciences Inc USNA
Common Stock
|
2014-10-31 | Option exercise | 4,491 | $28.16 | 126,467 |
|
Usana Health Sciences Inc USNA
Stock-Settled Stock Appreciation Rights · derivative
|
2014-10-31 | Option exercise | 6,000 | $0.00 | |
|
Usana Health Sciences Inc USNA
Stock-Settled Stock Appreciation Rights · derivative
|
2014-02-03 | Grant | 12,000 | $0.00 | |
|
Usana Health Sciences Inc USNA
Common Stock
|
2013-07-25 | Option exercise | 6,380 | $26.06 | 166,263 |
|
Usana Health Sciences Inc USNA
Stock-Settled Stock Appreciation Rights · derivative
|
2013-07-25 | Option exercise | 10,000 | $0.00 | |
|
Usana Health Sciences Inc USNA
Common Stock
|
2013-07-25 | Sell | 6,380 | $73.20 | 467,016 |
|
Usana Health Sciences Inc USNA
Common Stock
|
2012-12-10 | Sell | 5,000 | $43.17 | 215,850 |